group_id,Component_6,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_04737,2.3485315968442158,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_01261,1.931001044416988,FUN_005023-T1,Peve_00028649,Pocillopora_meandrina_HIv1___RNAseq.g8329.t1,three_way,83.2865,FUN_005023-T1,A2BEA6,,,,,62.1,195.0,1.3e-58,228.8,sp|A2BEA6|ARI3A_DANRE AT-rich interactive domain-containing protein 3A OS=Danio rerio OX=7955 GN=arid3a PE=1 SV=1,,,,,,
OG_06522,1.867953909749102,FUN_029339-T1,Peve_00023361,Pocillopora_meandrina_HIv1___RNAseq.g17301.t1,three_way,61.434333333333335,FUN_029339-T1,Q01973,ROR1_HUMAN,,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",Homo sapiens (Human),31.6,773.0,1.1000000000000001e-118,429.1,sp|Q01973|ROR1_HUMAN Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens OX=9606 GN=ROR1 PE=1 SV=2,GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0015026; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092,astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0006355; GO:0016740; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_01437,1.825272383207228,FUN_005873-T1,Peve_00015756,Pocillopora_meandrina_HIv1___RNAseq.g19664.t1,three_way,58.21833333333333,,,,,,,,,,,,,,,,,
OG_01656,1.8239275302781384,FUN_006826-T1,Peve_00023770,Pocillopora_meandrina_HIv1___RNAseq.g20475.t1,three_way,76.18166666666667,,,,,,,,,,,,,,,,,
OG_07762,1.8120335063438795,FUN_034956-T1,Peve_00036680,Pocillopora_meandrina_HIv1___RNAseq.g27836.t1,three_way,74.127,FUN_034956-T1,P39949,CCNE1_RAT,,G1/S-specific cyclin-E1,Rattus norvegicus (Rat),51.8,311.0,1.5e-85,318.2,sp|P39949|CCNE1_RAT G1/S-specific cyclin-E1 OS=Rattus norvegicus OX=10116 GN=Ccne1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0001547; GO:0001889; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0006270; GO:0007129; GO:0009410; GO:0014074; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0031100; GO:0031670; GO:0032355; GO:0032570; GO:0032880; GO:0033197; GO:0034097; GO:0044877; GO:0045471; GO:0045597; GO:0048545; GO:0051301; GO:0051412; GO:0051597; GO:0051726; GO:0070192; GO:0097134; GO:1900087; GO:1902462,animal organ regeneration [GO:0031100]; antral ovarian follicle growth [GO:0001547]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to progesterone [GO:0032570]; response to purine-containing compound [GO:0014074]; response to steroid hormone [GO:0048545]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016740; GO:0022414; GO:0032200; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; transferase activity; reproductive process; telomere organization; organelle; anatomical structure development; molecular function regulator activity
OG_07103,1.807987860288128,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_04195,1.805256011341602,FUN_016720-T1,Peve_00014673,Pocillopora_meandrina_HIv1___RNAseq.g230.t1,three_way,61.32066666666666,FUN_016720-T1,Q64729,TGFR1_MOUSE,,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),Mus musculus (Mouse),38.4,487.0,5.7e-74,280.0,sp|Q64729|TGFR1_MOUSE TGF-beta receptor type-1 OS=Mus musculus OX=10090 GN=Tgfbr1 PE=1 SV=1,GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001935; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0005929; GO:0006915; GO:0007179; GO:0007507; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0016020; GO:0030199; GO:0030307; GO:0030335; GO:0030336; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0035556; GO:0036446; GO:0042118; GO:0043065; GO:0043066; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046847; GO:0046872; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0050431; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060391; GO:0060395; GO:0060412; GO:0060978; GO:0060982; GO:0061450; GO:0070021; GO:0070411; GO:0070723; GO:0071560; GO:1901203; GO:1902462; GO:1904018; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237,activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; cilium [GO:0005929]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021],"ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005929; GO:0006355; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; nucleoplasm; endosome; plasma membrane; cilium; regulation of DNA-templated transcription; programmed cell death; transferase activity; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_02599,1.7490262825064502,FUN_010720-T1,Peve_00029905,Pocillopora_meandrina_HIv1___RNAseq.g20949.t2,three_way,83.7885,FUN_010720-T1,P58197,AP2A_RAT,,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),Rattus norvegicus (Rat),63.4,227.0,3.3e-68,260.8,sp|P58197|AP2A_RAT Transcription factor AP-2-alpha OS=Rattus norvegicus OX=10116 GN=Tfap2a PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001501; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:1990837; GO:2000378,anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559],clathrin-coated pit [GO:0005905]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0012501; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; extracellular matrix organization; organelle; anatomical structure development; cell motility; nervous system process; molecular adaptor activity; transcription regulator activity
OG_01210,1.720319394402838,FUN_004887-T1,Peve_00005850,Pocillopora_meandrina_HIv1___RNAseq.g10661.t1,three_way,61.143166666666666,FUN_004887-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),31.4,1097.0,1.9e-124,450.7,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00252,1.68483440705789,FUN_001016-T1,Peve_00041043,Pocillopora_meandrina_HIv1___RNAseq.g29160.t1,three_way,48.55133333333333,FUN_001016-T1,Q0IHU9,,,,,42.9,203.0,7.6e-44,180.6,sp|Q0IHU9|PRUN2_XENTR Protein prune homolog 2 OS=Xenopus tropicalis OX=8364 GN=Prune2 PE=2 SV=1,,,,,,
OG_09757,1.6749376862590926,FUN_042029-T1,Peve_00025063,Pocillopora_meandrina_HIv1___RNAseq.g15174.t1,three_way,47.64533333333333,FUN_042029-T1,Q9QYM2,,,,,31.9,354.0,1.1e-38,163.7,sp|Q9QYM2|PARG_RAT Poly(ADP-ribose) glycohydrolase OS=Rattus norvegicus OX=10116 GN=Parg PE=1 SV=1,,,,,,
OG_03500,1.658192721818308,FUN_014610-T1,Peve_00027567,Pocillopora_meandrina_HIv1___TS.g27529.t1,three_way,75.49566666666666,FUN_014610-T1,P27465,,,,,48.5,361.0,3.7e-97,356.7,"sp|P27465|PISD_CRIGR Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Cricetulus griseus OX=10029 GN=Pisd PE=1 SV=2",,,,,,
OG_07956,1.655675610174122,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_03911,1.6407118850831472,FUN_015990-T1,Peve_00023998,Pocillopora_meandrina_HIv1___RNAseq.g21387.t1,three_way,69.50233333333334,FUN_015990-T1,Q5BIM1,,,,,25.3,490.0,3.2e-30,135.2,sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1,,,,,,
OG_05395,1.6351423248359165,FUN_024222-T1,Peve_00031895,Pocillopora_meandrina_HIv1___RNAseq.g18914.t1,three_way,77.07900000000001,FUN_024222-T1,Q13887,KLF5_HUMAN,,Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2),Homo sapiens (Human),38.6,166.0,5.3e-19,96.7,sp|Q13887|KLF5_HUMAN Krueppel-like factor 5 OS=Homo sapiens OX=9606 GN=KLF5 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0008270; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0060576; GO:0061586; GO:1901653; GO:1990830; GO:1990837,angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816],chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005654; GO:0005794; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleoplasm; Golgi apparatus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_01407,1.6335846344061198,FUN_005476-T1,Peve_00041489,Pocillopora_meandrina_HIv1___RNAseq.g6630.t1,three_way,45.82566666666667,,,,,,,,,,,,,,,,,
OG_07052,1.6118562863030064,FUN_032274-T1,Peve_00011763,Pocillopora_meandrina_HIv1___RNAseq.g24974.t1,three_way,68.399,FUN_032274-T1,A8E7N9,,,,,31.6,370.0,2.9e-44,181.0,sp|A8E7N9|GDF6B_DANRE Growth/differentiation factor 6-B OS=Danio rerio OX=7955 GN=gdf6b PE=2 SV=1,,,,,,
OG_08396,1.6078807637658945,FUN_037010-T1,Peve_00032338,Pocillopora_meandrina_HIv1___RNAseq.g26698.t1,three_way,85.58966666666667,FUN_037010-T1,Q8N2G6,,,,,56.0,234.0,5.3e-63,242.7,sp|Q8N2G6|ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 OS=Homo sapiens OX=9606 GN=ZCCHC24 PE=1 SV=1,,,,,,
OG_04336,1.6047656253397615,FUN_017948-T1,Peve_00000381,Pocillopora_meandrina_HIv1___RNAseq.g25232.t1,three_way,82.87233333333333,,,,,,,,,,,,,,,,,
OG_01447,1.5839703124585556,FUN_005896-T1,Peve_00035817,Pocillopora_meandrina_HIv1___RNAseq.3177_t,three_way,67.3925,FUN_005896-T1,Q8K2Y0,,,,,39.0,141.0,1.2e-15,86.3,sp|Q8K2Y0|OBI1_MOUSE ORC ubiquitin ligase 1 OS=Mus musculus OX=10090 GN=Obi1 PE=1 SV=2,,,,,,
OG_03658,1.5690854465743054,FUN_014895-T1,Peve_00003547,Pocillopora_meandrina_HIv1___RNAseq.g21105.t1,three_way,67.7525,FUN_014895-T1,Q0VH32,,,,,50.8,122.0,6.3999999999999975e-25,116.3,sp|Q0VH32|MNT_XENLA Max-binding protein MNT OS=Xenopus laevis OX=8355 GN=mnt PE=2 SV=1,,,,,,
OG_07554,1.5629080323365785,FUN_034149-T1,Peve_00026010,Pocillopora_meandrina_HIv1___TS.g23718.t1b,three_way,50.663833333333336,,,,,,,,,,,,,,,,,
OG_07519,1.5502719889915078,FUN_034088-T1,Peve_00037071,Pocillopora_meandrina_HIv1___RNAseq.g26059.t1,three_way,77.17566666666667,FUN_034088-T1,Q4V920,PACN1_DANRE,,Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1),Danio rerio (Zebrafish) (Brachydanio rerio),36.1,449.0,4.1e-70,266.9,sp|Q4V920|PACN1_DANRE Protein kinase C and casein kinase substrate in neurons protein 1 OS=Danio rerio OX=7955 GN=pacsin1b PE=1 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0006897; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0060271; GO:0097320; GO:1900006,actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; regulation of endocytosis [GO:0030100],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; neuron projection [GO:0043005]; ruffle membrane [GO:0032587]; synapse [GO:0045202],phospholipid binding [GO:0005543],GO:0005768; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0044782; GO:0061024,endosome; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; cilium organization; membrane organization
OG_08046,1.5436722161691447,FUN_035734-T1,Peve_00044083,Pocillopora_meandrina_HIv1___RNAseq.g11861.t1,three_way,58.831,FUN_035734-T1,Q8C080,,,,,51.9,162.0,2.9e-41,171.0,sp|Q8C080|SNX16_MOUSE Sorting nexin-16 OS=Mus musculus OX=10090 GN=Snx16 PE=1 SV=2,,,,,,
OG_05757,1.5336579162096404,FUN_025692-T1,Peve_00005578,Pocillopora_meandrina_HIv1___RNAseq.g13161.t2,three_way,54.39333333333333,,,,,,,,,,,,,,,,,
OG_08520,1.530933833373996,FUN_037452-T1,Peve_00044119,Pocillopora_meandrina_HIv1___RNAseq.g1368.t1,three_way,59.91483333333333,FUN_037452-T1,Q9IA95,,,,,32.7,266.0,2.4e-45,184.1,sp|Q9IA95|SFRP3_CHICK Secreted frizzled-related protein 3 OS=Gallus gallus OX=9031 GN=FRZB PE=2 SV=1,,,,,,
OG_09611,1.530029556301988,FUN_041769-T1,Peve_00041575,Pocillopora_meandrina_HIv1___RNAseq.g15246.t1,three_way,89.10266666666666,,,,,,,,,,,,,,,,,
OG_04170,1.510441312867132,FUN_016651-T1,Peve_00042780,Pocillopora_meandrina_HIv1___TS.g6961.t1,three_way,81.653,FUN_016651-T1,Q6TMK4,POXA_DICDI,,Peroxinectin A (EC 1.11.1.7),Dictyostelium discoideum (Social amoeba),34.7,521.0,3.3e-86,322.0,sp|Q6TMK4|POXA_DICDI Peroxinectin A OS=Dictyostelium discoideum OX=44689 GN=poxA PE=1 SV=1,GO:0004447; GO:0004601; GO:0005576; GO:0005783; GO:0006955; GO:0006979; GO:0020037; GO:0036393; GO:0042742; GO:0042744; GO:0140825,defense response to bacterium [GO:0042742]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; response to oxidative stress [GO:0006979],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; lactoperoxidase activity [GO:0140825]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393],GO:0002376; GO:0003824; GO:0005576; GO:0005783; GO:0016209; GO:0016491; GO:0043226,immune system process; catalytic activity; extracellular region; endoplasmic reticulum; antioxidant activity; oxidoreductase activity; organelle
OG_08633,1.509833100752501,FUN_037802-T1,Peve_00026129,Pocillopora_meandrina_HIv1___RNAseq.g1562.t1,three_way,59.398,,,,,,,,,,,,,,,,,
OG_02049,1.5013285045675493,FUN_008259-T1,Peve_00042075,Pocillopora_meandrina_HIv1___RNAseq.g17963.t1,three_way,74.48566666666667,FUN_008259-T1,O88559,MEN1_MOUSE,,Menin,Mus musculus (Mouse),42.6,599.0,3.6e-116,420.2,sp|O88559|MEN1_MOUSE Menin OS=Mus musculus OX=10090 GN=Men1 PE=1 SV=2,GO:0000122; GO:0000781; GO:0000976; GO:0001216; GO:0001503; GO:0001776; GO:0002051; GO:0002076; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006338; GO:0008283; GO:0008285; GO:0010468; GO:0010628; GO:0017053; GO:0030097; GO:0035097; GO:0035265; GO:0043565; GO:0044342; GO:0044346; GO:0045668; GO:0045669; GO:0045815; GO:0045893; GO:0045944; GO:0046621; GO:0048144; GO:0048147; GO:0048704; GO:0048863; GO:0051301; GO:0051781; GO:0060021; GO:0060135; GO:0072089; GO:1904691; GO:2000045; GO:2000271; GO:2000647; GO:2000738,cell division [GO:0051301]; cell population proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; embryonic skeletal system morphogenesis [GO:0048704]; fibroblast apoptotic process [GO:0044346]; fibroblast proliferation [GO:0048144]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; organ growth [GO:0035265]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of cell division [GO:0051781]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription initiation-coupled chromatin remodeling [GO:0045815]; type B pancreatic cell proliferation [GO:0044342],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976],GO:0002376; GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04439,1.4958259780762766,FUN_018835-T2,Peve_00035787,Pocillopora_meandrina_HIv1___RNAseq.g9856.t1,three_way,77.22033333333333,FUN_018835-T2,Q9C0G6,DYH6_HUMAN,,Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6),Homo sapiens (Human),37.1,4337.0,0.0,2654.0,sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_08930,1.4841652821303726,FUN_038392-T1,Peve_00000048,Pocillopora_meandrina_HIv1___RNAseq.g28264.t1,three_way,76.04899999999999,FUN_038392-T1,P16065,,,,,36.6,998.0,4.3999999999999996e-160,567.0,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_07066,1.4827109704859256,FUN_032299-T1,Peve_00020128,Pocillopora_meandrina_HIv1___RNAseq.g24900.t1,three_way,50.632333333333335,FUN_032299-T1,Q3ZT31,SNX25_MOUSE,,Sorting nexin-25,Mus musculus (Mouse),27.2,125.0,1.3e-07,60.8,sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3,GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091,negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801],endosome [GO:0005768]; endosome membrane [GO:0010008],phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005768; GO:0008289; GO:0031410; GO:0043226,endosome; lipid binding; cytoplasmic vesicle; organelle
OG_01330,1.4777768077833036,FUN_005220-T1,Peve_00035492,Pocillopora_meandrina_HIv1___TS.g19865.t1,three_way,97.09066666666666,FUN_005220-T1,Q9TTR8,,,,,73.7,266.0,5e-111,402.1,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_02853,1.4736632865218184,FUN_011890-T1,Peve_00042786,Pocillopora_meandrina_HIv1___RNAseq.g13675.t1,three_way,73.18133333333333,FUN_011890-T1,Q9ULI1,,,,,28.0,898.0,2.4e-78,296.2,sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3,,,,,,
OG_03061,1.4577832768370824,FUN_012325-T1,Peve_00022885,Pocillopora_meandrina_HIv1___RNAseq.g23751.t1,three_way,82.00566666666667,FUN_012325-T1,Q8R3S2,TSN33_MOUSE,,Tetraspanin-33 (Tspan-33) (Penumbra) (mPen) (Proerythroblast new membrane),Mus musculus (Mouse),45.7,258.0,7.699999999999999e-56,218.8,sp|Q8R3S2|TSN33_MOUSE Tetraspanin-33 OS=Mus musculus OX=10090 GN=Tspan33 PE=1 SV=1,GO:0005737; GO:0005912; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197,pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197],enzyme binding [GO:0019899],GO:0051604; GO:0065003; GO:0072659,protein maturation; protein-containing complex assembly; protein localization to plasma membrane
OG_07351,1.4547112450824375,FUN_033759-T1,Peve_00009253,Pocillopora_meandrina_HIv1___RNAseq.g28744.t1,three_way,61.443,FUN_033759-T1,Q28005,LSHR_BOVIN,,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Bos taurus (Bovine),36.1,498.0,3.2000000000000003e-80,301.6,sp|Q28005|LSHR_BOVIN Lutropin-choriogonadotropic hormone receptor OS=Bos taurus OX=9913 GN=LHCGR PE=2 SV=1,GO:0001541; GO:0004964; GO:0005886; GO:0007189; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_05110,1.4394260442017988,FUN_023369-T2,Peve_00005354,Pocillopora_meandrina_HIv1___TS.g17121.t2,three_way,69.55983333333333,FUN_023369-T2,O96028,NSD2_HUMAN,,Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein),Homo sapiens (Human),41.5,1229.0,2.6e-223,777.3,sp|O96028|NSD2_HUMAN Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens OX=9606 GN=NSD2 PE=1 SV=1,GO:0000122; GO:0000785; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006355; GO:0008270; GO:0032259; GO:0042799; GO:0043565; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:0140938; GO:0140954; GO:0140955; GO:2001032,atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; double-strand break repair [GO:0006302]; membranous septum morphogenesis [GO:0003149]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H4K20 methyltransferase activity [GO:0042799]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07441,1.432184903896495,FUN_033933-T1,Peve_00020980,Pocillopora_meandrina_HIv1___RNAseq.g26583.t1,three_way,86.51866666666666,FUN_033933-T1,Q15915,ZIC1_HUMAN,,Zinc finger protein ZIC 1 (Zinc finger protein 201) (Zinc finger protein of the cerebellum 1),Homo sapiens (Human),37.8,249.0,1.7e-36,155.2,sp|Q15915|ZIC1_HUMAN Zinc finger protein ZIC 1 OS=Homo sapiens OX=9606 GN=ZIC1 PE=1 SV=2,GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007389; GO:0007417; GO:0007420; GO:0007628; GO:0008270; GO:0008589; GO:0010467; GO:0021510; GO:0021766; GO:0021772; GO:0030154; GO:0042307; GO:0042472; GO:0045893; GO:0098727; GO:1990837,adult walking behavior [GO:0007628]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; inner ear morphogenesis [GO:0042472]; maintenance of cell number [GO:0098727]; olfactory bulb development [GO:0021772]; pattern specification process [GO:0007389]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_10198,1.4301295558801603,FUN_043622-T1,Peve_00008234,Pocillopora_meandrina_HIv1___RNAseq.g6927.t1,three_way,76.94266666666667,FUN_043622-T1,Q9VUX3,NOTUM_DROME,,Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (Protein Notum) (Protein wingful) (dNOTUM),Drosophila melanogaster (Fruit fly),28.2,347.0,8.8e-26,119.8,sp|Q9VUX3|NOTUM_DROME Palmitoleoyl-protein carboxylesterase NOTUM OS=Drosophila melanogaster OX=7227 GN=Notum PE=1 SV=3,GO:0005615; GO:0007419; GO:0009986; GO:0016055; GO:0035220; GO:0035222; GO:0045880; GO:0048076; GO:0048190; GO:0048546; GO:0090090; GO:1990697; GO:1990699,digestive tract morphogenesis [GO:0048546]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of smoothened signaling pathway [GO:0045880]; protein depalmitoleylation [GO:1990697]; regulation of compound eye pigmentation [GO:0048076]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; extracellular space [GO:0005615],palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005615; GO:0016787; GO:0030163; GO:0048856,catalytic activity; extracellular space; hydrolase activity; protein catabolic process; anatomical structure development
OG_04041,1.4230670535138898,FUN_016350-T1,Peve_00004331,Pocillopora_meandrina_HIv1___RNAseq.16312_t,three_way,70.639,FUN_016350-T1,Q90WR8,SP3_CHICK,,Transcription factor Sp3,Gallus gallus (Chicken),48.7,117.0,7.9e-20,100.1,sp|Q90WR8|SP3_CHICK Transcription factor Sp3 OS=Gallus gallus OX=9031 GN=SP3 PE=1 SV=1,GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001779; GO:0001889; GO:0002318; GO:0003682; GO:0005829; GO:0006357; GO:0008270; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0043353; GO:0045944; GO:0048596; GO:0048706; GO:0060216; GO:0061629,B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; myeloid progenitor cell differentiation [GO:0002318]; natural killer cell differentiation [GO:0001779]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217],cytosol [GO:0005829]; PML body [GO:0016605]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_08095,1.4227633625415272,FUN_035833-T1,Peve_00002593,Pocillopora_meandrina_HIv1___RNAseq.g11963.t1,three_way,82.79166666666667,FUN_035833-T1,O74212,,,,,49.9,443.0,1.9999999999999999e-128,460.7,sp|O74212|D5FAD_MORAP Acyl-lipid (8-3)-desaturase OS=Mortierella alpina OX=64518 GN=DES1 PE=1 SV=1,,,,,,
OG_03671,1.418752058785166,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_06993,1.418342736313964,FUN_032139-T1,Peve_00007913,Pocillopora_meandrina_HIv1___TS.g24062.t1,three_way,49.26766666666666,,,,,,,,,,,,,,,,,
OG_01475,1.413097230469876,FUN_006038-T1,Peve_00023433,Pocillopora_meandrina_HIv1___RNAseq.g20251.t1,three_way,65.71133333333333,FUN_006038-T1,Q7T2C4,S26A5_DANRE,,Prestin (Solute carrier family 26 member 5),Danio rerio (Zebrafish) (Brachydanio rerio),37.0,686.0,1.8e-115,418.3,sp|Q7T2C4|S26A5_DANRE Prestin OS=Danio rerio OX=7955 GN=slc26a5 PE=2 SV=1,GO:0005737; GO:0005886; GO:0006821; GO:0008271; GO:0015075; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0016020; GO:0019531; GO:0019532; GO:0042391; GO:0160044; GO:0160046; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; oxalate transport [GO:0019532]; regulation of membrane potential [GO:0042391]; sulfate transmembrane transport [GO:1902358],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; formate transmembrane transporter activity [GO:0015499]; monoatomic ion transmembrane transporter activity [GO:0015075]; oxalate transmembrane transporter activity [GO:0019531]; oxalate:chloride antiporter activity [GO:0160046]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_00308,1.4118309247187462,FUN_001110-T1,Peve_00029335,Pocillopora_meandrina_HIv1___RNAseq.g29363.t1,three_way,71.534,FUN_001110-T1,P15384,,,,,49.9,407.0,2.3e-84,314.7,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_07861,1.404323560691574,FUN_035216-T2,Peve_00035892,Pocillopora_meandrina_HIv1___RNAseq.g27615.t1,three_way,70.04816666666666,FUN_035216-T2,Q503Z8,IRX6A_DANRE,,Iroquois homeobox protein 6a,Danio rerio (Zebrafish) (Brachydanio rerio),47.6,233.0,1.9e-40,168.3,sp|Q503Z8|IRX6A_DANRE Iroquois homeobox protein 6a OS=Danio rerio OX=7955 GN=irx6a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030182; GO:0048468,cell development [GO:0048468]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_08704,1.3974407472868078,FUN_037953-T1,Peve_00040733,Pocillopora_meandrina_HIv1___RNAseq.g26512.t1,three_way,50.168,FUN_037953-T1,Q91905,,,,,68.3,60.0,4.7e-18,92.8,sp|Q91905|FXI1B_XENLA Forkhead box protein I1-B OS=Xenopus laevis OX=8355 GN=foxi1-b PE=2 SV=1,,,,,,
OG_05731,1.3966382684283598,FUN_025657-T1,Peve_00042176,Pocillopora_meandrina_HIv1___RNAseq.g23075.t1,three_way,71.07683333333333,FUN_025657-T1,P17863,,,,,33.1,341.0,1.1e-45,186.4,sp|P17863|SKI_AVIES Transforming protein Ski OS=Avian erythroblastosis virus (strain Sloan-Kettering) OX=11862 GN=V-SKI PE=1 SV=1,,,,,,
OG_03792,1.3913211713561584,FUN_015158-T1,Peve_00001862,Pocillopora_meandrina_HIv1___RNAseq.g21765.t1,three_way,81.74516666666666,FUN_015158-T1,Q96DH6,,,,,47.2,335.0,2.3e-67,257.7,sp|Q96DH6|MSI2H_HUMAN RNA-binding protein Musashi homolog 2 OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=1,,,,,,
OG_05208,1.3907544592229917,FUN_023592-T1,Peve_00023919,Pocillopora_meandrina_HIv1___RNAseq.g3311.t1,three_way,44.60383333333333,FUN_023592-T1,E9PVX6,KI67_MOUSE,,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog),Mus musculus (Mouse),42.2,135.0,5.7e-18,95.9,sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1,GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072089; GO:0072574; GO:0140693; GO:1902275; GO:1990705,cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088]; stem cell proliferation [GO:0072089],"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0007059; GO:0022414; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; chromosome; nucleolus; chromosome segregation; reproductive process; organelle; molecular adaptor activity
OG_00234,1.386480537087372,FUN_000988-T1,Peve_00022149,Pocillopora_meandrina_HIv1___RNAseq.g29209.t1,three_way,82.41166666666666,FUN_000988-T1,Q92828,,,,,47.6,401.0,3.4e-101,370.5,sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2,,,,,,
OG_05437,1.38372230289548,FUN_024390-T2,Peve_00018042,Pocillopora_meandrina_HIv1___RNAseq.g18621.t1,three_way,74.62266666666667,FUN_024390-T2,Q80VL3,,,,,50.8,413.0,3e-126,454.1,sp|Q80VL3|PRIC3_MOUSE Prickle planar cell polarity protein 3 OS=Mus musculus OX=10090 GN=Prickle3 PE=1 SV=1,,,,,,
OG_05498,1.3767991886428712,FUN_024557-T1,Peve_00039513,Pocillopora_meandrina_HIv1___RNAseq.g18656.t1,three_way,51.671,,,,,,,,,,,,,,,,,
OG_07088,1.3733087341714594,FUN_032345-T1,Peve_00021405,Pocillopora_meandrina_HIv1___RNAseq.g29797.t2,three_way,70.41966666666667,FUN_032345-T1,Q9V3L1,NDST_DROME,,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)],Drosophila melanogaster (Fruit fly),46.3,901.0,9.6e-236,818.1,sp|Q9V3L1|NDST_DROME Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase OS=Drosophila melanogaster OX=7227 GN=sfl PE=1 SV=1,GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008543; GO:0008587; GO:0015012; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140,"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]",endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139],deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate N-sulfotransferase activity [GO:0015016],GO:0003824; GO:0005783; GO:0005794; GO:0006790; GO:0009101; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; hydrolase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_03926,1.371066008664875,FUN_016038-T1,Peve_00011807,Pocillopora_meandrina_HIv1___RNAseq.g21648.t2,three_way,64.21833333333333,FUN_016038-T1,Q8TDN4,CABL1_HUMAN,,CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1),Homo sapiens (Human),43.4,295.0,2.7e-61,237.7,sp|Q8TDN4|CABL1_HUMAN CDK5 and ABL1 enzyme substrate 1 OS=Homo sapiens OX=9606 GN=CABLES1 PE=1 SV=2,GO:0005634; GO:0005829; GO:0007399; GO:0051301; GO:0051726,cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726],cytosol [GO:0005829]; nucleus [GO:0005634],,GO:0005634; GO:0005829; GO:0043226; GO:0048856,nucleus; cytosol; organelle; anatomical structure development
OG_07679,1.3689286308156765,FUN_034797-T1,Peve_00007517,Pocillopora_meandrina_HIv1___RNAseq.g12297.t1,three_way,79.21333333333334,FUN_034797-T1,D3ZDI6,MYLIP_RAT,,E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP),Rattus norvegicus (Rat),43.0,440.0,5.1e-96,353.2,sp|D3ZDI6|MYLIP_RAT E3 ubiquitin-protein ligase MYLIP OS=Rattus norvegicus OX=10116 GN=Mylip PE=2 SV=1,GO:0004842; GO:0005737; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0008270; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0061630,cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886],cytoskeletal protein binding [GO:0008092]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00953,1.365227365775168,FUN_004313-T1,Peve_00033929,Pocillopora_meandrina_HIv1___RNAseq.g16987.t1,three_way,67.48483333333334,FUN_004313-T1,Q90693,,,,,37.8,1339.0,2e-235,817.8,sp|Q90693|PTC1_CHICK Protein patched homolog 1 OS=Gallus gallus OX=9031 GN=PTCH1 PE=1 SV=1,,,,,,
OG_04006,1.3636845839709353,FUN_016305-T1,Peve_00032293,Pocillopora_meandrina_HIv1___RNAseq.g10040.t1,three_way,94.53566666666669,FUN_016305-T1,Q6NZ04,SIX1B_DANRE,,Homeobox protein six1b (Homeobox protein six1a) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,285.0,6.9e-92,338.6,sp|Q6NZ04|SIX1B_DANRE Homeobox protein six1b OS=Danio rerio OX=7955 GN=six1b PE=1 SV=1,GO:0000978; GO:0000981; GO:0002074; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0014857; GO:0021984; GO:0043282; GO:0048741; GO:0048839; GO:0048935; GO:0051146,adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; chordate pharyngeal muscle development [GO:0043282]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; peripheral nervous system neuron development [GO:0048935]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146],cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_08091,1.3623730881409233,FUN_035824-T1,Peve_00037802,Pocillopora_meandrina_HIv1___RNAseq.g11933.t1,three_way,90.67833333333334,FUN_035824-T1,P08239,,,,,72.6,354.0,3e-148,526.2,sp|P08239|GNAO_BOVIN Guanine nucleotide-binding protein G(o) subunit alpha OS=Bos taurus OX=9913 GN=GNAO1 PE=1 SV=4,,,,,,
OG_01489,1.3602130886355486,FUN_006165-T1,Peve_00023607,Pocillopora_meandrina_HIv1___RNAseq.g20426.t1,three_way,60.60533333333333,FUN_006165-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),33.7,5014.0,0.0,2299.2,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_05551,1.359305843144646,FUN_024758-T1,Peve_00027326,Pocillopora_meandrina_HIv1___RNAseq.g18826.t1,three_way,87.74933333333333,,,,,,,,,,,,,,,,,
OG_00679,1.3579818578057918,FUN_002102-T1,Peve_00004294,Pocillopora_meandrina_HIv1___RNAseq.g1737.t1,three_way,59.12716666666666,FUN_002102-T1,P18461,,,,,37.9,833.0,3.8e-141,503.8,sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus OX=9031 GN=FGFR2 PE=2 SV=1,,,,,,
OG_05473,1.3575465389057002,FUN_024456-T1,Peve_00010312,Pocillopora_meandrina_HIv1___RNAseq.g18574.t1,three_way,77.98883333333333,FUN_024456-T1,A7S6A1,,,,,59.2,903.0,2.2000000000000002e-272,939.9,sp|A7S6A1|U518_NEMVE FHIP family protein v1g243165 OS=Nematostella vectensis OX=45351 GN=v1g243165 PE=3 SV=1,,,,,,
OG_00986,1.3560826081872746,FUN_004373-T2,Peve_00007253,Pocillopora_meandrina_HIv1___TS.g17451.t1,three_way,60.50866666666667,FUN_004373-T2,P16621,,,,,38.6,2020.0,0.0,1295.0,sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2,,,,,,
OG_05220,1.3503078202231382,FUN_023632-T1,Peve_00017477,Pocillopora_meandrina_HIv1___RNAseq.g527.t1,three_way,59.04733333333333,,,,,,,,,,,,,,,,,
OG_04285,1.3494498853651773,FUN_017848-T2,Peve_00013267,Pocillopora_meandrina_HIv1___RNAseq.g9584.t1a,three_way,68.80566666666667,FUN_017848-T2,Q09328,MGT5A_HUMAN,,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]",Homo sapiens (Human),37.0,873.0,6.1e-166,586.3,"sp|Q09328|MGT5A_HUMAN Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Homo sapiens OX=9606 GN=MGAT5 PE=1 SV=1",GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1904894,positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]",GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_07760,1.346965846297684,FUN_034954-T1,Peve_00036673,Pocillopora_meandrina_HIv1___RNAseq.g27838.t1,three_way,81.57233333333333,FUN_034954-T1,Q9NXC2,GFOD1_HUMAN,,Glucose-fructose oxidoreductase domain-containing protein 1 (Gfo/Idh/MocA-like oxidoreductase domain-containing protein 1),Homo sapiens (Human),45.3,371.0,7.8e-92,339.0,sp|Q9NXC2|GFOD1_HUMAN Glucose-fructose oxidoreductase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GFOD1 PE=1 SV=1,GO:0000166; GO:0005576; GO:0016491; GO:0042802,,extracellular region [GO:0005576],identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005576; GO:0016491,catalytic activity; extracellular region; oxidoreductase activity
OG_02090,1.3400416659746577,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_09535,1.325036879340104,FUN_041622-T1,Peve_00036084,Pocillopora_meandrina_HIv1___TS.g10312.t1b,three_way,81.132,FUN_041622-T1,P41247,PLPL4_HUMAN,,Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2),Homo sapiens (Human),48.4,248.0,4.7999999999999995e-61,236.1,sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3,GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088,lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739],"acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806]",GO:0003824; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_07408,1.3146343305008348,FUN_033861-T1,Peve_00043296,Pocillopora_meandrina_HIv1___RNAseq.g28415.t1,three_way,63.10766666666667,FUN_033861-T1,Q95JR6,,,,,28.8,295.0,3.5e-27,124.8,sp|Q95JR6|CNBD2_MACFA Cyclic nucleotide-binding domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=CNBD2 PE=2 SV=1,,,,,,
OG_08170,1.3106636957852806,FUN_035976-T1,Peve_00006611,Pocillopora_meandrina_HIv1___RNAseq.g12335.t1,three_way,78.89066666666666,FUN_035976-T1,Q8BVR6,,,,,56.2,489.0,3e-152,540.0,sp|Q8BVR6|RSPRY_MOUSE RING finger and SPRY domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rspry1 PE=1 SV=1,,,,,,
OG_00243,1.310476780355582,FUN_001006-T1,Peve_00015278,Pocillopora_meandrina_HIv1___RNAseq.g29174.t1,three_way,60.991,FUN_001006-T1,Q498G2,,,,,27.4,727.0,1.3e-40,171.0,sp|Q498G2|CE152_XENLA Centrosomal protein of 152 kDa OS=Xenopus laevis OX=8355 GN=cep152 PE=2 SV=1,,,,,,
OG_06203,1.3046335416686223,FUN_028139-T1,Peve_00025714,Pocillopora_meandrina_HIv1___RNAseq.g16451.t1,three_way,81.30433333333333,FUN_028139-T1,A1L3P4,SL9A6_MOUSE,,Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Sodium/hydrogen exchanger) (Solute carrier family 9 member 6),Mus musculus (Mouse),55.7,587.0,3.3e-153,543.5,sp|A1L3P4|SL9A6_MOUSE Sodium/hydrogen exchanger 6 OS=Mus musculus OX=10090 GN=Slc9a6 PE=1 SV=1,GO:0005739; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0015385; GO:0015386; GO:0030010; GO:0030425; GO:0031410; GO:0031547; GO:0031901; GO:0031902; GO:0043679; GO:0044308; GO:0045202; GO:0048675; GO:0048812; GO:0050808; GO:0051386; GO:0051453; GO:0055037; GO:0055038; GO:0060996; GO:0097484; GO:0098685; GO:0098978; GO:0099072; GO:1902600,axon extension [GO:0048675]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; dendrite extension [GO:0097484]; dendritic spine development [GO:0060996]; establishment of cell polarity [GO:0030010]; neuron projection morphogenesis [GO:0048812]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; synapse organization [GO:0050808],axon terminus [GO:0043679]; axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202],potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005739; GO:0005768; GO:0005886; GO:0007163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0055085,transporter activity; mitochondrion; endosome; plasma membrane; establishment or maintenance of cell polarity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; transmembrane transport
OG_01366,1.303163234950944,FUN_005313-T1,Peve_00003312,Pocillopora_meandrina_HIv1___RNAseq.g8174.t1,three_way,94.14516666666668,FUN_005313-T1,Q04727,TLE4_HUMAN,,Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4),Homo sapiens (Human),84.8,356.0,3.9e-180,632.1,sp|Q04727|TLE4_HUMAN Transducin-like enhancer protein 4 OS=Homo sapiens OX=9606 GN=TLE4 PE=1 SV=3,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0090090; GO:0140297; GO:1990830; GO:1990907,cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055],beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_07349,1.3004568400712038,FUN_033756-T1,Peve_00004915,Pocillopora_meandrina_HIv1___RNAseq.g28747.t1,three_way,85.5945,FUN_033756-T1,Q13136,LIPA1_HUMAN,,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),Homo sapiens (Human),45.4,1218.0,1.3e-187,658.7,sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1,GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077,cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444],,GO:0005829; GO:0007010; GO:0007155; GO:0034330; GO:0043226,cytosol; cytoskeleton organization; cell adhesion; cell junction organization; organelle
OG_05547,1.3002866645699984,FUN_024754-T1,Peve_00041144,Pocillopora_meandrina_HIv1___RNAseq.g18833.t1,three_way,62.28083333333333,FUN_024754-T1,Q9NXR5,,,,,41.9,93.0,3.5e-12,73.9,sp|Q9NXR5|ANR10_HUMAN Ankyrin repeat domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ANKRD10 PE=1 SV=2,,,,,,
OG_08627,1.2980497426206792,FUN_037795-T1,Peve_00026136,Pocillopora_meandrina_HIv1___RNAseq.g1555.t3,three_way,71.708,FUN_037795-T1,P51960,,,,,33.6,758.0,4.3e-85,317.4,sp|P51960|MYBA_MOUSE Myb-related protein A OS=Mus musculus OX=10090 GN=Mybl1 PE=1 SV=2,,,,,,
OG_03517,1.2946346724594695,FUN_014630-T1,Peve_00002417,Pocillopora_meandrina_HIv1___RNAseq.g22787.t1,three_way,63.39333333333334,FUN_014630-T1,Q5R5S1,,,,,31.7,612.0,1.1999999999999999e-75,285.8,sp|Q5R5S1|FBX21_PONAB F-box only protein 21 OS=Pongo abelii OX=9601 GN=FBXO21 PE=2 SV=1,,,,,,
OG_00866,1.287755733362636,FUN_004140-T2,Peve_00009429,Pocillopora_meandrina_HIv1___RNAseq.g11564.t1,three_way,92.6315,FUN_004140-T2,Q07343,PDE4B_HUMAN,,"3',5'-cyclic-AMP phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32) (cAMP-specific phosphodiesterase 4B)",Homo sapiens (Human),56.3,551.0,1.1000000000000001e-168,595.1,"sp|Q07343|PDE4B_HUMAN 3',5'-cyclic-AMP phosphodiesterase 4B OS=Homo sapiens OX=9606 GN=PDE4B PE=1 SV=1",GO:0000930; GO:0001780; GO:0004115; GO:0005246; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0008021; GO:0014069; GO:0019933; GO:0030018; GO:0030552; GO:0030593; GO:0032729; GO:0032743; GO:0043015; GO:0043197; GO:0044325; GO:0046872; GO:0047555; GO:0050852; GO:0050900; GO:0060076; GO:0071222; GO:0071466; GO:0071872; GO:0071878; GO:0086004; GO:1901898; GO:1902514,cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; leukocyte migration [GO:0050900]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of type II interferon production [GO:0032729]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell contraction [GO:0086004]; T cell receptor signaling pathway [GO:0050852],centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium channel regulator activity [GO:0005246]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]",GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0048870; GO:0055086; GO:0098772; GO:1901135,immune system process; catalytic activity; microtubule organizing center; cytosol; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; cell motility; nucleobase-containing small molecule metabolic process; molecular function regulator activity; carbohydrate derivative metabolic process
OG_07464,1.2873047346757645,FUN_033968-T1,Peve_00015220,Pocillopora_meandrina_HIv1___RNAseq.g28549.t1,three_way,90.424,FUN_033968-T1,Q9Y2H1,ST38L_HUMAN,,Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2),Homo sapiens (Human),71.3,442.0,1.3e-188,660.6,sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens OX=9606 GN=STK38L PE=1 SV=3,GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0010507; GO:0015629; GO:0016020; GO:0035556; GO:0051128; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005829; GO:0005856; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08835,1.284245178236726,FUN_038179-T1,Peve_00009439,Pocillopora_meandrina_HIv1___RNAseq.g965.t1,three_way,67.80166666666668,FUN_038179-T1,Q9Y4F3,,,,,28.7,1454.0,1.1e-132,476.9,sp|Q9Y4F3|MARF1_HUMAN Meiosis regulator and mRNA stability factor 1 OS=Homo sapiens OX=9606 GN=MARF1 PE=1 SV=6,,,,,,
OG_06973,1.2837176245700923,FUN_032108-T1,Peve_00030224,Pocillopora_meandrina_HIv1___RNAseq.g5393.t1,three_way,58.33233333333333,FUN_032108-T1,Q8IWX5,SGPP2_HUMAN,,Sphingosine-1-phosphate phosphatase 2 (SPPase2) (Spp2) (hSPP2) (EC 3.1.3.-) (Sphingosine-1-phosphatase 2),Homo sapiens (Human),34.5,403.0,2.3e-56,221.1,sp|Q8IWX5|SGPP2_HUMAN Sphingosine-1-phosphate phosphatase 2 OS=Homo sapiens OX=9606 GN=SGPP2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0006670; GO:0030149; GO:0042392; GO:0046839; GO:0061469; GO:0070780,phospholipid dephosphorylation [GO:0046839]; regulation of type B pancreatic cell proliferation [GO:0061469]; sphingolipid catabolic process [GO:0030149]; sphingosine metabolic process [GO:0006670],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],dihydrosphingosine-1-phosphate phosphatase activity [GO:0070780]; sphingosine-1-phosphate phosphatase activity [GO:0042392],GO:0003824; GO:0005783; GO:0006629; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; hydrolase activity; organelle
OG_03683,1.276840065445925,FUN_014942-T1,Peve_00037148,Pocillopora_meandrina_HIv1___RNAseq.g21099.t1,three_way,86.43466666666666,FUN_014942-T1,Q8AX98,TBX1A_XENLA,,T-box transcription factor TBX1-A (T-box protein 1-A),Xenopus laevis (African clawed frog),74.0,196.0,1.3e-84,315.1,sp|Q8AX98|TBX1A_XENLA T-box transcription factor TBX1-A OS=Xenopus laevis OX=8355 GN=tbx1-a PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0003700; GO:0005634; GO:0006357; GO:0045944; GO:0050793; GO:0060788; GO:0071300,cell fate specification [GO:0001708]; cellular response to retinoic acid [GO:0071300]; ectodermal placode formation [GO:0060788]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_00588,1.2766931235632628,FUN_001671-T2,Peve_00038393,Pocillopora_meandrina_HIv1___RNAseq.g29390.t1,three_way,54.833666666666666,FUN_001671-T2,O60293,,,,,28.7,1468.0,5.8000000000000005e-133,478.0,sp|O60293|ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein OS=Homo sapiens OX=9606 GN=ZFC3H1 PE=1 SV=3,,,,,,
OG_07864,1.275074406870293,FUN_035221-T1,Peve_00035886,Pocillopora_meandrina_HIv1___RNAseq.g27610.t1,three_way,84.449,FUN_035221-T1,Q6DE14,E2F4_XENLA,,Transcription factor E2F4 (E2F-4),Xenopus laevis (African clawed frog),54.9,368.0,1.1e-96,354.8,sp|Q6DE14|E2F4_XENLA Transcription factor E2F4 OS=Xenopus laevis OX=8355 GN=e2f4 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003700; GO:0006357; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251,centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0006355; GO:0030154; GO:0044782; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; cilium organization; transcription regulator activity
OG_01740,1.2734631800626066,FUN_007062-T1,Peve_00025326,Pocillopora_meandrina_HIv1___RNAseq.g20109.t1,three_way,70.79983333333334,FUN_007062-T1,Q8IX03,KIBRA_HUMAN,,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),Homo sapiens (Human),29.0,1136.0,8.3e-51,204.1,sp|Q8IX03|KIBRA_HUMAN Protein KIBRA OS=Homo sapiens OX=9606 GN=WWC1 PE=1 SV=1,GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0035329; GO:0035330; GO:0035331; GO:0035591; GO:0043410; GO:0046621; GO:0048471; GO:0060090,cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587],kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0007163; GO:0043226; GO:0048870; GO:0060090; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_01002,1.2733950390328357,FUN_004421-T1,Peve_00026932,Pocillopora_meandrina_HIv1___RNAseq.g16665.t1,three_way,58.136,FUN_004421-T1,F1NWE3,,,,,29.1,1542.0,2.5e-170,601.7,sp|F1NWE3|PTPRS_CHICK Receptor-type tyrosine-protein phosphatase S OS=Gallus gallus OX=9031 GN=PTPRS PE=1 SV=3,,,,,,
OG_04075,1.2728303008862447,FUN_016400-T1,Peve_00006411,Pocillopora_meandrina_HIv1___RNAseq.g9752.t1,three_way,83.30466666666666,FUN_016400-T1,Q6NUP7,PP4R4_HUMAN,,Serine/threonine-protein phosphatase 4 regulatory subunit 4,Homo sapiens (Human),46.8,667.0,3.4e-166,587.0,sp|Q6NUP7|PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PPP4R4 PE=1 SV=1,GO:0001835; GO:0004864; GO:0004865; GO:0005737; GO:0005829; GO:0005929; GO:0008287; GO:0019888; GO:0036064; GO:0043231,blastocyst hatching [GO:0001835],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase complex [GO:0008287],protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],GO:0005815; GO:0005829; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; cilium; organelle; molecular function regulator activity
OG_01276,1.2728109590336607,FUN_005056-T1,Peve_00016747,Pocillopora_meandrina_HIv1___RNAseq.g8303.t1,three_way,56.921,FUN_005056-T1,P42568,AF9_HUMAN,,Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3),Homo sapiens (Human),38.0,92.0,2.1e-09,65.1,sp|P42568|AF9_HUMAN Protein AF-9 OS=Homo sapiens OX=9606 GN=MLLT3 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007379; GO:0008023; GO:0009952; GO:0010467; GO:0042393; GO:0045893; GO:0060090; GO:0060218; GO:0070062; GO:0070577; GO:0090090; GO:0140030; GO:0140044; GO:0140072; GO:0140119; GO:1902275; GO:2000035; GO:2000096,"anterior/posterior pattern specification [GO:0009952]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of chromatin organization [GO:1902275]; regulation of stem cell division [GO:2000035]; segment specification [GO:0007379]",chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; histone H3K9ac reader activity [GO:0140072]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; molecular adaptor activity [GO:0060090],GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0060090,DNA binding; nucleus; nucleoplasm; chromosome; cytosol; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; molecular adaptor activity
OG_00361,1.2718946535836382,FUN_001195-T1,Peve_00006935,Pocillopora_meandrina_HIv1___RNAseq.g29525.t1,three_way,41.97683333333333,,,,,,,,,,,,,,,,,
OG_05572,1.2700788806312815,FUN_024815-T1,Peve_00026076,Pocillopora_meandrina_HIv1___RNAseq.g18772.t1,three_way,69.34433333333334,FUN_024815-T1,Q96PE2,ARHGH_HUMAN,,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),Homo sapiens (Human),40.1,1066.0,9.2e-179,630.2,sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056,actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0007010; GO:0098772,cytosol; cytoskeleton organization; molecular function regulator activity
OG_02043,1.269493398189761,FUN_008248-T1,Peve_00031792,Pocillopora_meandrina_HIv1___RNAseq.g17952.t2,three_way,55.662,FUN_008248-T1,P83618,,,,,25.9,185.0,9.7e-14,78.6,sp|P83618|RN28_PANGI Ribonuclease-like storage protein OS=Panax ginseng OX=4054 PE=1 SV=2,,,,,,
OG_08856,1.268582712142699,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_00020,1.267945298856845,FUN_000216-T1,Peve_00018873,Pocillopora_meandrina_HIv1___RNAseq.g28926.t1,three_way,52.28366666666667,,,,,,,,,,,,,,,,,
OG_03546,1.2679226140224902,FUN_014673-T1,Peve_00013033,Pocillopora_meandrina_HIv1___RNAseq.g22680.t1,three_way,77.56683333333334,FUN_014673-T1,Q96AY4,TTC28_HUMAN,,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),Homo sapiens (Human),44.3,828.0,5.7e-171,604.4,sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4,GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301,cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922],kinase binding [GO:0019900],GO:0005815,microtubule organizing center
OG_02300,1.2671239819293658,FUN_008879-T1,Peve_00043354,Pocillopora_meandrina_HIv1___RNAseq.g14471.t1,three_way,77.52583333333332,FUN_008879-T1,O93310,,,,,39.9,642.0,2.8e-79,297.7,sp|O93310|RAD21_XENLA Double-strand-break repair protein rad21 homolog OS=Xenopus laevis OX=8355 GN=rad21 PE=1 SV=1,,,,,,
OG_06310,1.2653992569435546,FUN_028549-T1,Peve_00000746,Pocillopora_meandrina_HIv1___RNAseq.g6218.t1,three_way,56.03633333333333,FUN_028549-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),30.5,285.0,4.8e-29,131.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_07102,1.264704159076658,FUN_032363-T1,Peve_00045030,Pocillopora_meandrina_HIv1___RNAseq.g29819.t1,three_way,59.871500000000005,FUN_032363-T1,Q6N021,TET2_HUMAN,,Methylcytosine dioxygenase TET2 (EC 1.14.11.80),Homo sapiens (Human),32.8,825.0,5.8e-99,364.4,sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3,GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579; GO:0141167,"chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]",chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0009101; GO:0016491; GO:0030154; GO:0043226; GO:0140097; GO:1901135,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; glycoprotein biosynthetic process; oxidoreductase activity; cell differentiation; organelle; catalytic activity, acting on DNA; carbohydrate derivative metabolic process"
